BACKGROUND. T cells expressing antigen-specific chimeric antigen receptors (CARs)
improve outcomes for CD19-expressing B cell malignancies. We evaluated a human …

We evaluated 917 adult lymphoma patients who received haploidentical (n= 185) or HLA-
matched unrelated donor (URD) transplantation either with (n= 241) or without …

Simple Summary Mantle Cell Lymphoma (MCL) is a lymphoproliferative disorder which
represents less than 10% of all non-Hodgkin Lymphomas. The typical course of MCL is …

Cure of malignant and non-malignant hematological diseases is potentially possible after
allogeneic hematopoietic stem cell transplantation (HCT). Accurate evaluation of the risk …

For diffuse large B‐cell lymphoma (DLBCL) patients progressing after autologous
haematopoietic cell transplantation (auto HCT), allogeneic HCT (allo HCT) is often …

Radiotherapy is potentially an important salvage strategy post‐chimeric antigen receptor T
cell therapy (CART), but limited data exist. We reviewed 14 patients treated with salvage …

Mantle cell lymphoma (MCL) is an incurable aggressive non-Hodgkin lymphoma (NHL),
which accounts for approximately 5% of all NHL. Novel agents and rituximab maintenance …

Abstract Purpose of Review Tauopathies represent a spectrum of incurable and progressive
age-associated neurodegenerative diseases that currently are diagnosed definitively only at …

Non-Hodgkin's lymphoma (NHL) constitutes a collection of lymphoproliferative disorders
with diverse biologic, histologic, and clinical features. With a better understanding of the …

The accurate detection and precise assessment of therapeutic responses is critical to the
optimal management of patients with lymphoma. Over the past 50 years, dramatic advances …